DODEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dodex, and what generic alternatives are available?
Dodex is a drug marketed by Accord Hlthcare and is included in one NDA.
The generic ingredient in DODEX is cyanocobalamin. There is one drug master file entry for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dodex
A generic version of DODEX was approved as cyanocobalamin by PADAGIS ISRAEL on September 9th, 2020.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DODEX?
- What are the global sales for DODEX?
- What is Average Wholesale Price for DODEX?
Summary for DODEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| Drug Prices: | Drug price information for DODEX |
| DailyMed Link: | DODEX at DailyMed |
US Patents and Regulatory Information for DODEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord Hlthcare | DODEX | cyanocobalamin | INJECTABLE;INJECTION | 083022-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
